Siolta Therapeutics, Inc.
STMC-106, a multistrain Live Biotherapeutic Product containing rationally designed bacterial consortia to prevent and treat necrotizing enterocolitis
- Sector
- Biotech
- Headquarters
- San Carlos, CA
- Total capital
- $4.7M
- Federal grants
- $4.7M
- 5 awards · 2022–2025
- Rank in peer group#127 of 514
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 2
- 19 pending · first 2022
- Rank in peer group#142 of 514
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · Development of a multispecies live biotherapeutic product for the prevention of recurrent bacterial vaginosis$529K
- Federal grantHealth and Human S · Phase II · Anaerobic Manufacturing and Molecular Analytical Process Optimization to Support Clinical Development of Live Biotherapeutic Products$949K
- Federal grantHealth and Human S · Phase I · A Synergistic Multistrain Live Biotherapeutic Product for the Prevention and Treatment of Necrotizing Enterocolitis$300K
- Federal grantHealth and Human S · Phase II · Anaerobic Manufacturing and Molecular Analytical Process Optimization to Support Clinical Development of Live Biotherapeutic Products$993K
- Federal grantHealth and Human S · Phase II · Anaerobic Manufacturing and Molecular Analytical Process Optimization to Support Clinical Development of Live Biotherapeutic Products$2M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 514 peers
Line = medianBiotech · Molecule
- Federal grants#127 · top 25%
- Granted patents#142 · top 28%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 2 granted of 21- PendingTherapeutic Pharmaceutical CompositionsUSPTOApplication 18943202
- PendingPharmaceutical Compositions And Uses ThereofUSPTOApplication 18967879
- PendingPharmaceutical Compositions And Uses ThereofUSPTOApplication 18502595
Show all 21 patent records
- Therapeutic Pharmaceutical CompositionsJul 3, 2025 · Application 18943202Pending
- Pharmaceutical Compositions And Uses ThereofJun 26, 2025 · Application 18967879Pending
- Pharmaceutical Compositions And Uses ThereofJun 6, 2024 · Application 18502595Pending
- Therapeutic Pharmaceutical CompositionsMay 30, 2024 · Application 18474503Pending
- Pharmaceutical Compositions For Treating DiseasesMar 21, 2024 · Application 18477009Pending
- Therapeutic Pharmaceutical CompositionsNov 7, 2023 · US 11,806,373Granted
- Therapeutic Pharmaceutical CompositionsAug 9, 2022 · US 11,406,675Granted
- Compositions For Disease TreatmentDec 9, 2021 · Application 17407111Pending
- Pharmaceutical Compositions For Treating DiseasesApplication 63171804Pending
- Therapeutic Pharmaceutical CompositionsApplication PCTUS2020054444Pending
- Compositions For Disease TreatmentApplication PCTUS2020019124Pending
- Therapeutic Pharmaceutical CompositionsApplication 62911873Pending
- Pharmaceutical Compositions For Treating Infant Gastrointestinal DiseasesApplication PCTUS2025056682Pending
- Compositions For Disease TreatmentApplication 62808140Pending
- Pharmaceutical Compositions For Treating Infant Gastrointestinal DiseasesApplication 63723949Pending
- Pharmaceutical Compositions And Uses ThereofApplication PCTUS2023068094Pending
- Pharmaceutical Compositions And Uses ThereofApplication 63350666Pending
- Pharmaceutical Compositions And Uses ThereofApplication PCTUS2022030847Pending
- Pharmaceutical Compositions For Treating DiseasesApplication PCTUS2022023710Pending
- Pharmaceutical Compositions And Uses ThereofApplication 63240264Pending
- Pharmaceutical Compositions And Uses ThereofApplication 63193300Pending
Related companies, and why
- Endlyz Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- Avilar TherapeuticsSimilar federal contract value in Biotech · null in contracts
- SUPERNUS PHARMACEUTICALS INCSimilar federal contract value in Biotech · null in contracts
- PEPTIDE LOGIC LLCSimilar federal contract value in Biotech · null in contracts
- Biomea Fusion, Inc.Similar federal contract value in Biotech · null in contracts
- Azitra Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .